Phase 1 clinical trial

February 12, 2020February 12, 2020

UPenn Researchers Awarded $500K Grant to Develop CAR T-cell Therapy for Advanced PC

News

A research team at the Abramson Cancer Center of the University of Pennsylvania has been awarded a $500,000 grant from the Alliance for Cancer Gene Therapy (ACGT) to develop a ... Read more

January 30, 2019January 30, 2019

FDA Clears Phase 1 Trial of ARV-110 for Advanced Prostate Cancer

News

The U.S. Food and Drug Administration has signed off on Arvinas‘ first Phase 1 clinical trial to evaluate ARV-110 as a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). The ... Read more